Science Business : (Record no. 4356)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02188nam a2200241Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | ASM |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241206092904.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241203s9999 xx 000 0 und d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | HD9999.B442 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 97815913984 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781591398400 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Qualifying information | Hardback |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ASM |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gary P. Pisano |
| Relator term | Author |
| 245 #0 - TITLE STATEMENT | |
| Title | Science Business : |
| Remainder of title | "The Promise, The Reality and the Future of Biotech" |
| Statement of responsibility, etc. | Gary P. Pisano. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | "Boston, Massachusetts" |
| Name of publisher, distributor, etc. | Harvard Business School Press |
| Date of publication, distribution, etc. | 2006 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 237 Pages |
| Other physical details | "Graphs, Flow charts, Bars" |
| Dimensions | 24 cm |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "Why has the biotechnology industry failed to perform up to expectationsdespite all its promise? In Science Business, Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorterterm 'monetisation' of intellectual property. Pisano maintains that all industry playersbiotech firms, investors, universities, pharmaceutical companies, government regulatorscan play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being." |
| 546 ## - LANGUAGE NOTE | |
| Language note | English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | "Social Sciences-Miscellaneous industries and trades, Biotechnology industries--History." |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | |
No items available.